Academic Publication De novo designed proteins neutralize lethal snake venom toxins
Research Abstract & Technology Focus
Snakebite envenoming remains a devastating and neglected tropical disease, claiming over 100,000 lives annually and causing severe complications and long-lasting disabilities for many more
1,2
. Three-finger toxins (3FTx) are highly toxic components of elapid snake venoms that can cause diverse pathologies, including severe tissue damage
3
and inhibition of nicotinic acetylcholine receptors, resulting in life-threatening neurotoxicity
4
. At present, the only available treatments for snakebites consist of polyclonal antibodies derived from the plasma of immunized animals, which have high cost and limited efficacy against 3FTxs
5–7
. Here we used deep learning methods to de novo design proteins to bind short-chain and long-chain α-neurotoxins and cytotoxins from the 3FTx family. With limited experimental screening, we obtained protein designs with remarkable thermal stability, high binding affinity and near-atomic-level agreement with the computational models. The designed proteins effectively neutralized all three 3FTx subfamilies in vitro and protected mice from a lethal neurotoxin challenge. Such potent, stable and readily manufacturable toxin-neutralizing proteins could provide the basis for safer, cost-effective and widely accessible next-generation antivenom therapeutics. Beyond snakebite, our results highlight how computational design could help democratize therapeutic discovery, particularly in resource-limited settings, by substantially reducing costs and resource requirements for the development of therapies for neglected tropical diseases.
AI Semantic Synergy Context
Connecting this academic literature to real-world market discussions and products.
De novo designed proteins neutralize lethal snake venom toxins
Abstract Snakebite envenoming remains a devastating and neglected tropical disease, claiming over 100,000 lives annually and causing severe complications and ...
Molecular Biology
The de novo design of miniproteins and the reclassification of 'dark proteins' signify significant advancements in synthetic biology and fundamental molecular discovery. This drives demand for B2B ...
BindCraft: one-shot design of functional protein binders
Abstract Protein–protein interactions (PPIs) are at the core of all key biological processes. However, the complexity of the structural features that determine PP...
Diverse binding poses of agonistic neurotoxins on human Nav1.6
Structures of the distinct binding poses of three agonistic peptide toxins—bullet-ant-derived toxin δ-paraponeritoxin-Pc1a, cone snail ι-conotoxin RXIA and the globular β-scorpion toxin Cn2—on the ...
A survey of generative AI for de novo drug design: new frontiers in molecule and protein generation
Abstract Artificial intelligence (AI)-driven methods can vastly improve the historically costly drug design process, with various generative models already in widespread use. Generat...
Frequently Asked Questions (FAQ)
Curated market intelligence mapped to this research.
What is the core focus of the research titled 'De novo designed proteins neutralize lethal snake venom toxins'?
This literature focuses on: Abstract Snakebite envenoming remains a devastating and neglected tropical disease, claiming over 100,000 lives annually and causing severe complications and long-lasting disabilities for many more ...
Are there open-source GitHub repositories related to De novo designed proteins neutralize lethal snake venom toxins?
Yes, open-source projects like slowmist/openclaw-security-practice-guide (This guide is designed for OpenClaw itself (Agent-facing), not as a traditional human-only hardening checklist.) are actively building upon these concepts.
Which startups are commercializing the technology behind De novo designed proteins neutralize lethal snake venom toxins?
Products like Tiny Aya are bringing this to market. Their focus is: Local, open-weight AI designed for real-world languages.
What other academic literature is closely related to 'De novo designed proteins neutralize lethal snake venom toxins'?
Yes, highly correlated activity was mapped. An entry titled 'De novo designed proteins neutralize lethal snake venom toxins' discusses this: Abstract Snakebite envenoming remains a devastating and neglected tropical disease, claiming over 100,000 li...
Are there commercial applications of 'De novo designed proteins neutralize lethal snake venom toxins' in market news publications?
Yes, highly correlated activity was mapped. An entry titled 'Molecular Biology' discusses this: The de novo design of miniproteins and the reclassification of 'dark proteins' signify significant advancements in synthetic biology and fundamenta...
Cite this Market Intelligence Report
Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.
Commercial Realization
Startups and Open Source tools heavily associated with the concepts explored in this paper.
-
GitHubslowmist/openclaw-security-practice-guide
-
GitHubDingTalk-Real-AI/dingtalk-workspace-cli
-
Product HuntTiny Aya
-
Product HuntClaude Code Desktop App Redesigned
SaaS Metrics